PROGRAM SPONSORS 1:30 PM Welcome Remarks Chancellor Mark S. Wrighton Washington University in St. Louis

1:35 PM Introduction of Professor Kurt T. Dirks Dr. F. Sessions Cole, MD Washington University in St. Louis

1:40 - 2:30 PM Keynote Presentation Dr. Francis Sessions Cole, MD Washington University in St. Louis Personalized Medicine: From Genomic Discovery to Clinical Impact 2:35 - 3:25 PM Panel Discussion PANELISTS Business Strategies for the Dr. Frank Jiang Future of Healthcare CStone Pharmaceuticals Mr. Guy Mills Manulife Mr. Sean Shan 3:25 - 3:55 PM Takeda and Takeda Coffee/Tea Break Greater China Dr. Justin Xiang Syno Capital 3:55 PM GengHong (Rebecca) WEI Introduction of Professor James V. Wertsch Dr. Robert Schreiber, PhD Washington University in St. Louis & XingSheng (Ray) YANG 4:00 - 5:00 PM Keynote Presentation Dr. Robert D. Schreiber, PhD Washington University in St. Louis Immunological Approaches to Managing Disease Washington University in St. Louis 5:05 - 5:45 PM Panel Discussion PANELISTS Dr. Pui-Yan Kwok FORUM FOR GREATER CHINA Trends in the Science and Academia Sinica Philip Rong Practice of Personalized Dr. Jin Li & Island Shangri-La Hong Kong | December 14, 2018 Medicine in Greater China Fudan University Dr. Joseph Sung Willow Yang The Chinese

5:45 PM Closing Remarks Chancellor Mark S. Wrighton 6:00 - 7:00 PM ERSONALIZED EDICINE AND THE Reception THANK YOU P M 7:00 - 9:00 PM Regional Cabinet Dinner FUTURE OF HEALTH CARE All Attendees Invited

FORUM2018_Programv3.pages.pdf 1 12/6/18 10:1310:15 AM Washington University in St. Louis 1:35 PM 3:55 PM Introduction of Dr. Robert Schreiber, PhD FORUM FOR GREATER CHINA Introduction of Dr. Francis Sessions Cole, MD KURT T. DIRKS JAMES V. WERTSCH PERSONALIZED MEDICINE AND THE FUTURE OF HEALTH CARE WASHINGTON UNIVERSITY IN ST. LOUIS WASHINGTON UNIVERSITY IN ST. LOUIS Through its McDonnell International Scholars Academy, Washington University has developed Kurt Dirks is the Vice Chancellor for International Affairs and incoming Director James Wertsch is the David R. Francis Distinguished Professor, Director of the close, strategic partnerships over the past decade within Greater China. These partners of the McDonnell International Scholars Academy for Washington University. McDonnell International Scholars Academy, and Professor of Anthropology at include China Agricultural University, The Chinese University of Hong Kong, Fudan University, He also holds the position of Bank of America Professor of Leadership at the Washington University. Wertsch received his Ph.D. at the University of Chicago and Hong Kong University of Science and Technology, National Chiao Tung University, National Olin Business School. He received a Ph.D. from the University of Minnesota. spent a postdoctoral fellow in Moscow at Moscow State University. He has been a Taiwan University, Peking University, Tsinghua University, The University of Hong Kong, and Kurt’s research is in the field of Organizational Behavior, and focuses on issues visiting professor at the University of Utrecht, Moscow State University, the Xi’an Jiaotong University. related to leadership and teams. He is best known for his research on the University of Seville, and the University of Oslo. Wertsch is a Fellow of the determinants, barriers, and outcomes of trust within organizations and has American Academy of Arts and Sciences and serves as a guest professor at the After several decades of engagement, Washington University is positioned to have an even published a number of highly recognized articles on the topic. University of Oslo in Norway, Tsinghua University in Beijing, and at Fudan more substantial presence and impact in greater China. This one-day conference is an University in . opportunity to bring together business leaders, public officials, and university faculty and alumni to explore important issues affecting Greater China today. 1:40 - 2:30 PM 4:00 - 5:00 PM Keynote Presentation Washington University’s Forum for Greater China will explore the issues of personalized Keynote Presentation medicine and the future of health care in order to stimulate additional collaborative research Personalized Medicine: From Genomic Discovery to Clinical Impact Immunological Approaches to Managing Disease that will advance global solutions to these challenges. Washington University experts will FRANCIS SESSIONS COLE, III, MD ROBERT D. SCHREIBER, PHD provide insight through two keynote speeches, followed by panel discussions with leading WASHINGTON UNIVERSITY IN ST. LOUIS WASHINGTON UNIVERSITY IN ST. LOUIS U.S. and Chinese corporate, government, and educational leaders. Francis Sessions Cole, M.D., is the Park J. White, M.D., Professor of Pediatrics Robert D. Schreiber, Ph.D. is the Andrew M. and Jane M. Bursky Distinguished and Assistant Vice Chancellor for Children’s Health at Washington University in Professor in the Department of Pathology and Immunology and Professor of St. Louis. Dr. Cole came to Washington University in 1986 after graduating Molecular Microbiology at Washington University School of Medicine. He earned from Yale University School of Medicine and receiving his clinical and post- his PhD from State University of New York at Buffalo in Biochemistry and AGENDA doctoral training in Pediatrics and Neonatal-Perinatal Medicine at Boston Immunology and became a Fellow at Scripps Institute before he moved to Harvard Children’s Hospital and Harvard Medical School. His interest in newborn Medical School. 1:30 PM infants has led him to apply state of the art, personalized medicine techniques Dr. Schreiber is the Director of the Bursky Center for Human Immunology and Welcome Remarks to discover new genetic causes of structural birth defects and of respiratory Immunotherapy Programs; an Extramural Member Researcher of the Parker failure in full-term infants. Institute for Cancer Immunotherapy; Associate Director of the SAB to the CRI; and MARK S. WRIGHTON Leading local, national and international interdisciplinary teams of investigators, a member of the BSA to the NCI. WASHINGTON UNIVERSITY IN ST. LOUIS he has also discovered new genetic diseases, expanded phenotypes of known Chancellor He has authored over 300 publications and has received many honors including genetic diseases, and suggested novel therapeutic strategies. He leads the the William Coley Award for Distinguished Research in Basic and Tumor Dr. Mark S. Wrighton is Chancellor and Professor of Chemistry at National Institute of Health-funded Washington University Undiagnosed Immunology from the CRI; the Charles Rodolphe Brupbacher Prize for Cancer Washington University in St. Louis since July 1, 1995. Since his arrival, Diseases Network Clinical Site, which is focused on shortening the diagnostic Research; the Lloyd J. Old Prize in Cancer Immunology awarded by the AACR and Washington University has made unprecedented progress in campus journeys of both pediatric and adult patients with undiagnosed diseases by the CRI and the Balzan Prize (shared with James Allison): Immunological improvements, resource development, curriculum, international reputation, leveraging the rich personalized medicine resources at Washington University. Approaches in Cancer Therapy. Schreiber is a Fellow of the American Association and especially in undergraduate applications and student quality. for the Advancement of Science, a member of the American Academy of Arts and Chancellor Wrighton served as a presidential appointee to the National 2:35 - 3:25 PM Sciences and the U.S. National Academy of Sciences. Science Board (2000-06). He is a past chair of the Business-Higher Panel Discussion 5:05 - 5:45 PM Education Forum and the Association of American Universities. Business Strategies for the Future of Healthcare Panel Discussion Trends in the Science and Practice of Personalized Medicine in Greater China Wrighton has received many awards for his research and scholarly writing, PANELISTS | WashU Alumni including the distinguished MacArthur Prize. He is also the holder of an PANELISTS honorary doctorate from Fudan University. He is the author of over 300 FRANK JIANG, Medical School Fellowship CEO, CStone Pharmaceuticals Co Ltd articles in professional and scholarly journals, is the holder of 16 patents, Director, Institute of Biomedical Sciences PUI-YAN KWOK and co-author of a book, Organometallic Photochemistry. GUY MILLS, EMOF’11 CEO, Manulife Hong Kong Academia Sinica Wrighton received his B.S. degree with honors in chemistry from Florida President, Takeda China and State University in 1969 and his Ph.D. in chemistry from the California SEAN SHAN, EMOF’08 JIN LI Vice President, Fudan University Area Head, Takeda Greater China Institute of Technology in 1972. JOSEPH J.Y. SUNG Professor, The Chinese University of Hong Kong Chief Investment Officer and Co-Founder, JUSTIN XIANG, EN’04, GR’13 Syno Capital

Please visit global.wustl.edu to access full bios of speakers and panelists. Please visit global.wustl.edu to access full bios of speakers and panelists.

FORUM2018_Programv3.pages.pdf 2 12/6/18 10:1510:16 AM